Introduction
Brand name: Fexicrade 550 mg
Manufacturer: Astemax Biotech
Composition: Rifaximin 550 mg tablet
Fexicrade 550 mg is an intestinal‑acting antibiotic tablet containing rifaximin 550 mg, a non‑systemically absorbed rifamycin‑class agent. It works by inhibiting bacterial RNA synthesis in the gut, thereby controlling susceptible enteric pathogens while having minimal absorption into the bloodstream.
Key indications
Treatment of infectious diarrhoea and traveller’s diarrhoea caused by susceptible organisms (e.g., certain E. coli strains).
Management of irritable bowel syndrome with diarrhoea (IBS‑D) and reduction of recurrence episodes in hepatic encephalopathy by suppressing ammonia‑producing gut bacteria.
Dosage and precautions
Typical adult dose is 550 mg twice daily for a short duration (usually 3 days for traveller’s diarrhoea and several weeks for IBS‑D or hepatic encephalopathy), as per medical advice and local prescribing guidelines
